224 related articles for article (PubMed ID: 32941192)
1. Central nervous system injury from novel cancer immunotherapies.
Winter SF; Vaios EJ; Dietrich J
Curr Opin Neurol; 2020 Dec; 33(6):723-735. PubMed ID: 32941192
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy.
Perrinjaquet C; Desbaillets N; Hottinger AF
Curr Opin Neurol; 2019 Jun; 32(3):500-510. PubMed ID: 30893101
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Drugs and the Nervous System.
Santomasso BD
Continuum (Minneap Minn); 2020 Jun; 26(3):732-764. PubMed ID: 32487905
[TBL] [Abstract][Full Text] [Related]
4. Neurological complications of chimeric antigen receptor T cells and immune-checkpoint inhibitors: ongoing challenges in daily practice.
Berzero G; Picca A; Psimaras D
Curr Opin Oncol; 2020 Nov; 32(6):603-612. PubMed ID: 32852312
[TBL] [Abstract][Full Text] [Related]
5. Neurologic Toxicities of Cancer Immunotherapies: a Review.
Harrison RA; Tummala S; de Groot J
Curr Neurol Neurosci Rep; 2020 Jun; 20(7):27. PubMed ID: 32514633
[TBL] [Abstract][Full Text] [Related]
6. Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents.
Bompaire F; Birzu C; Bihan K; Desestret V; Fargeot G; Farina A; Joubert B; Leclercq D; Nichelli L; Picca A; Tafani C; Weiss N; Psimaras D; Ricard D
Rev Neurol (Paris); 2023 Jun; 179(5):405-416. PubMed ID: 37059646
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity of Cancer Immunotherapies Including CAR T Cell Therapy.
Song KW; Scott BJ; Lee EQ
Curr Neurol Neurosci Rep; 2023 Dec; 23(12):827-839. PubMed ID: 37938472
[TBL] [Abstract][Full Text] [Related]
8. Neurologic Toxicities of Immunotherapy.
Harrison RA; Majd NK; Tummala S; de Groot JF
Adv Exp Med Biol; 2021; 1342():417-429. PubMed ID: 34972978
[TBL] [Abstract][Full Text] [Related]
9. CAR-T and checkpoint inhibitors: toxicities and antidotes in the emergency department.
Lipe DN; Shafer S
Clin Toxicol (Phila); 2021 May; 59(5):376-385. PubMed ID: 33576256
[TBL] [Abstract][Full Text] [Related]
10. Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors.
Vilariño N; Bruna J; Kalofonou F; Anastopoulou GG; Argyriou AA
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796758
[TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.
Gupta S; Cortazar FB; Riella LV; Leaf DE
Kidney360; 2020 Feb; 1(2):130-140. PubMed ID: 35372904
[TBL] [Abstract][Full Text] [Related]
12. Neurological toxicities associated with immune-checkpoint inhibitors.
Touat M; Talmasov D; Ricard D; Psimaras D
Curr Opin Neurol; 2017 Dec; 30(6):659-668. PubMed ID: 28938341
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy induced enterocolitis and gastritis - What to do and when?
Cheung VTF; Brain O
Best Pract Res Clin Gastroenterol; 2020; 48-49():101703. PubMed ID: 33317787
[TBL] [Abstract][Full Text] [Related]
14. Neurologic Complications of Cancer Immunotherapy.
Wang N
Continuum (Minneap Minn); 2023 Dec; 29(6):1827-1843. PubMed ID: 38085900
[TBL] [Abstract][Full Text] [Related]
15. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I; Diab A; Abdallah K; Bingham CO; Brogdon C; Dadu R; Hamad L; Kim S; Lacouture ME; LeBoeuf NR; Lenihan D; Onofrei C; Shannon V; Sharma R; Silk AW; Skondra D; Suarez-Almazor ME; Wang Y; Wiley K; Kaufman HL; Ernstoff MS;
J Immunother Cancer; 2017 Nov; 5(1):95. PubMed ID: 29162153
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.
Reynolds KL; Guidon AC
Oncologist; 2019 Apr; 24(4):435-443. PubMed ID: 30482825
[TBL] [Abstract][Full Text] [Related]
17. Neurological Immunotoxicity from Cancer Treatment.
Wesley SF; Haggiagi A; Thakur KT; De Jager PL
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201529
[TBL] [Abstract][Full Text] [Related]
18. Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians.
Hryniewicki AT; Wang C; Shatsky RA; Coyne CJ
J Emerg Med; 2018 Oct; 55(4):489-502. PubMed ID: 30120013
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity.
Finch EA; Duke E; Hwang EI; Packer RJ
Pediatr Neurol; 2020 Jun; 107():7-15. PubMed ID: 32113728
[TBL] [Abstract][Full Text] [Related]
20. Neurological complications of cancer immunotherapy.
Roth P; Winklhofer S; Müller AMS; Dummer R; Mair MJ; Gramatzki D; Le Rhun E; Manz MG; Weller M; Preusser M
Cancer Treat Rev; 2021 Jun; 97():102189. PubMed ID: 33872978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
